{"url_path":"/sec/piii/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1832511/0001832511-26-000022-index.html","accession_number":"0001832511-26-000022","cik":"0001832511","ticker":"PIII","issuer_name":"P3 Health Partners Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1832511/0001832511-26-000022-index.html","primary_entity_key":"0001832511","primary_entity_name":"P3 Health Partners Inc."},"word_count":75,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\n(a) None.\n\n(b) None.\n\n(c) Insider Trading Arrangements and Policies.\n\nDuring the quarter ended March 31, 2026, no director or “officer” (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.\n\nP3 Health Partners Inc. | Q1 2026 Form 10-Q | 38\n\n[Table of Contents](#ifef36b214a484cbbbc50398c1ced2e35_10)"}